Tools commonly used in the Biotechnology Products & Services industry for day-to-day tasks and operations.

• DNA sequencers
• Microarray scanners
• Bioreactors
• Chromatography systems
• Mass spectrometers
• Flow cytometers
• Microscopes
• Electrophoresis systems
• PCR machines
• Cell culture systems
• CRISPR/Cas9 gene editing tools
• Protein purification systems
• High-throughput screening systems
• Bioinformatics software
• Lab automation systems
• Imaging systems
• Spectrophotometers
• Microplate readers
• Liquid handling systems

Common products and services typical of NAICS Code 541714-22, illustrating the main business activities and contributions to the market.

• Gene therapy
• Biofuels
• Biopharmaceuticals
• Agricultural biotechnology
• Industrial enzymes
• Biodegradable plastics
• Stem cell research
• Diagnostic testing
• Environmental biotechnology
• Animal health products
• Bioremediation
• Synthetic biology
• Biomaterials
• Food biotechnology
• Biopesticides
• Contract research services
• Microbial fermentation
• Tissue engineering
• Biosensors

The specific certifications, permits, licenses, and regulatory compliance requirements within the United States for this industry.

• Good Manufacturing Practice (GMP): GMP certification ensures that the products are consistently produced and controlled according to quality standards. The certification is provided by the US Food and Drug Administration (FDA).
• ISO 13485: ISO 13485 is an international standard that specifies requirements for a quality management system specific to the medical devices industry. The certification is provided by the International Organization for Standardization (ISO).
• Clinical Laboratory Improvement Amendments (CLIA): CLIA certification is required for laboratories that test human specimens for health assessment or to diagnose, prevent, or treat disease. The certification is provided by the Centers for Medicare & Medicaid Services (CMS).
• United States Pharmacopeia (USP): USP certification ensures the quality, purity, and potency of medicines, dietary supplements, and food ingredients. The certification is provided by the United States Pharmacopeial Convention (USP).
• National Environmental Laboratory Accreditation Program (NELAP): NELAP certification is required for laboratories that analyze environmental samples. The certification is provided by the National Environmental Laboratory Accreditation Program (NELAP).

A concise historical narrative of NAICS Code 541714-22 covering global milestones and recent developments within the United States.

• The biotechnology industry has a long and rich history, dating back to the 1970s when the first genetically engineered organism was created. Since then, the industry has seen many notable advancements, including the development of the first recombinant DNA drug, the first genetically engineered vaccine, and the first genetically modified crop. In recent years, the industry has focused on developing new treatments for diseases such as cancer and Alzheimer's, as well as on improving agricultural yields through genetic modification. In the United States, the industry has been driven by a combination of government funding, private investment, and academic research, and has become a major contributor to the country's economy.

The anticipated future trajectory of the NAICS 541714-22 industry in the USA, offering insights into potential trends, innovations, and challenges expected to shape its landscape.

• Growth Prediction: Growing

  The biotechnology products and services industry in the USA is expected to continue its growth trajectory in the coming years. The industry is driven by the increasing demand for biotechnology products and services in various sectors such as healthcare, agriculture, and industrial applications. The COVID-19 pandemic has also highlighted the importance of biotechnology in developing vaccines and treatments, which has further boosted the industry's growth. The industry is expected to benefit from the increasing investment in research and development, advancements in technology, and the growing trend of personalized medicine. However, the industry also faces challenges such as regulatory hurdles, high development costs, and ethical concerns. Overall, the biotechnology products and services industry is poised for steady growth in the USA.

Recent groundbreaking advancements and milestones in the Biotechnology Products & Services industry, reflecting notable innovations that have reshaped its landscape.

• CRISPR Gene Editing Technology: CRISPR is a revolutionary gene editing technology that allows scientists to edit DNA with unprecedented precision. It has the potential to cure genetic diseases, create new therapies, and improve crop yields.
• CAR-T Cell Therapy: CAR-T cell therapy is a type of immunotherapy that uses a patient's own immune cells to fight cancer. It has shown promising results in treating certain types of blood cancers.
• MRNA Vaccines: mRNA vaccines are a new type of vaccine that use a small piece of genetic material to teach the body how to fight a virus. They have been used successfully in developing COVID-19 vaccines.
• Precision Medicine: Precision medicine is an approach to healthcare that takes into account individual variability in genes, environment, and lifestyle. It has the potential to improve patient outcomes and reduce healthcare costs.
• Synthetic Biology: Synthetic biology is a field that combines biology and engineering to create new biological systems and organisms. It has the potential to create new materials, fuels, and medicines.